This symposium explored the use of dissolution testing in the development and control of a range of dosage forms, with presentations on the pharmacopoeial methods that are available, equipment requirements with respect to qualification and calibration, and practical examples of how these methods are used during development and routine quality control.
The symposium discussed the relevance of dissolution testing for the Biopharmaceutics Classification System and in-vitro - in vivo correlations (IVIVC) and how it can support post-approval changes.

Final programme

PJ Report

Full report

Speakers' slides